The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. - Test2 - elhamkhani - TriplyDB

The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

http://www.wikidata.org/entity/Q41900708

about

The role of L-type amino acid transporter 1 in human tumors Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers.Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.Advances in neuro-oncology imaging.Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.Targeting L-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics.Amino acid PET and MR perfusion imaging in brain tumours.O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis.[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.18F-DOPA uptake parameters in glioma: effects of patients' characteristics and prior treatment history.Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma.Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma.Biological evaluation of new [(18) F]F-labeled synthetic amino acid derivatives as oncologic radiotracers.Usefulness of PET Imaging to Guide Treatment Options in Gliomas.Imaging melphalan therapy response in preclinical extramedullary myeloma with 18F-FDOPA and 18F-FDG PET.18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.

P2860

Q26775785-9246865D-F75E-4936-99AA-90142D37DD1B Q34348544-5402A26F-B892-43A3-A899-9FB3BC9E8FE5 Q35021768-083013E4-B332-45F7-8CDB-D4807557DF86 Q36045175-E11578F8-35A5-49DE-899F-E9413C87D6C2 Q36250739-55CAE868-9522-4131-8BB9-6FE3BEF75FC9 Q36339461-F7470099-E69E-4191-B68C-FDBDE19265A4 Q37580486-BA3269FC-4EF0-409D-83A2-C98F78D6A3AA Q38351134-515FD59A-2C4C-457D-9CA0-676140799C2D Q38476583-04134909-ED5E-4A51-846A-81F0C742C97A Q38691946-6B8738BE-AD1F-475B-86D1-8E8397919598 Q40333907-5E182F1E-77F6-4118-92A7-47AD3D3223F0 Q42362580-D3465C7B-7207-4C26-97C0-8999F3B47774 Q47560758-94FD47A6-276F-4179-A828-105C87A618EF Q47734339-FEBAB6DC-62D3-43F6-922D-5568AE95F7DB Q47894479-B4B7CC34-1536-4214-BDA8-375D574FDAFF Q48151456-A002BE2E-DE15-4298-9F8C-FAC03253C76F Q48630863-5808A25F-4FA5-4EDC-9AE0-97204921B6F6 Q48947048-CC5C7CFE-6164-41CB-B627-646174C26612 Q52716405-95631C74-BE0E-45D3-BB60-1B9F4154B389 Q54135407-055675DF-2274-40FE-8BB3-7EB0B811B3DA

P2860

The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

http://www.wikidata.org/entity/Q41900708

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

@en

type

label

The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

@en

prefLabel

The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

@en

P1433

Q41900708-215E9A2C-613A-4244-942A-7C35C45AC5A3

P1476

Q41900708-E440236F-9481-4ED0-BC98-3ECBB6E623B9

P2093

Q41900708-170E68F7-0BDC-48DF-9B78-D4CAAC866844

Q41900708-2299CAB2-0FE0-4351-9A1B-52C57E996DFF

Q41900708-63495220-C7E1-4B28-91AE-E9BD733DA6A8

Q41900708-811BD452-A7B1-4749-AA54-76C113A988FD

Q41900708-81222AB6-A5DC-4F9E-9BF4-8C65A7DD1714

Q41900708-916B8F3B-59AD-4B7F-930E-5C5CDF0158A5

Q41900708-A26840B1-F480-4093-9058-1EC9444C8621

Q41900708-B895ACEC-E578-482D-9462-006184CCA36B

Q41900708-B9EF5E9A-00B3-4D53-AF3C-E1151DF7E17C

Q41900708-BFA0EECD-A266-4A87-8CA4-C502FD67398D

P2860

Q41900708-0099160A-9A6B-4BCE-9D1B-0A939A90E499

Q41900708-09E654D8-C4FD-498F-9591-AFEFB0CEA756

Q41900708-11F36DE6-6CF7-4096-9154-6899BABD0131

Q41900708-1DB07E31-6D80-450C-8B23-FE9489F14A6E

Q41900708-1F40E5C8-5CD2-46A2-A13F-4976A2C0FC13

Q41900708-2487ED93-B8A4-4820-9E01-7882736FCBB4

Q41900708-26A430D5-9C8F-47DE-928E-ED36F9015078

Q41900708-2BEEB02F-DCE7-4CC1-88E0-DFB924882E32

Q41900708-2CD003C3-B32F-4223-9D9F-C0BAAEED80F7

Q41900708-393242C3-0F90-4CE6-A29E-47FA00CFAF9C

P2888

Q41900708-2760F93D-4C45-4666-895F-F487FEE430E4

P304

Q41900708-BFAA9993-C427-4520-A69A-FF518E6AE38E

P31

Q41900708-D1836661-8C20-488E-A409-FB1ED45A17CE

P356

Q41900708-B6713341-7F28-4CF0-9072-D8F082CFB225

P433

Q41900708-7E8DBF94-0FC3-4133-AEAE-EC96B9E2C46E

P478

Q41900708-307195D3-700D-4E48-B426-DB6BD6781A9E

P577

Q41900708-0EC834D3-9C27-44D5-96D6-50F8CB5DB400

P6179

Q41900708-1DDD63AA-5BD7-43FF-B583-A98DB9CD6A67

P698

Q41900708-5D5C1EA8-859C-4496-B5FE-DC16C896D5B6

P932

Q41900708-96610DEE-623D-425E-8558-C523BF97AC2E

P356

S11060-012-0986-1

P1433

Journal of Neuro-Oncology

P1476

The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

@en

P2093

Caterina Giannini

http://www.w3.org/2001/XMLSchema#string

Deanna H Pafundi

http://www.w3.org/2001/XMLSchema#string

Debra H Brinkmann

http://www.w3.org/2001/XMLSchema#string

Gaspar J Kitange

http://www.w3.org/2001/XMLSchema#string

Ian F Parney

http://www.w3.org/2001/XMLSchema#string

Jann N Sarkaria

http://www.w3.org/2001/XMLSchema#string

Jenny L Pokorny

http://www.w3.org/2001/XMLSchema#string

Judi A Ramiscal

http://www.w3.org/2001/XMLSchema#string

Nadia N Laack

http://www.w3.org/2001/XMLSchema#string

Ryan S Youland

http://www.w3.org/2001/XMLSchema#string

P2860

Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.

The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.

L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.

Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.

Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.

L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer.

L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.

LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer

P2888

s11060-012-0986-1

P304

11-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-012-0986-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043115207

http://www.w3.org/2001/XMLSchema#string

P698

23086431

http://www.w3.org/2001/XMLSchema#string

P932

3907171

http://www.w3.org/2001/XMLSchema#string